These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of somatostatin analogs in the management of rare tumors and diseases. Palmieri G; Montella L J Endocrinol Invest; 2003; 26(8 Suppl):89-91. PubMed ID: 15233221 [No Abstract] [Full Text] [Related]
4. Somatostatin receptors and breast cancer. Cameron Smith M; Orlando C; Serio M; Maggi M J Endocrinol Invest; 2003; 26(8 Suppl):125-30. PubMed ID: 15233228 [No Abstract] [Full Text] [Related]
5. The effects of somatostatin analogs on biochemical parameters in acromegaly. Liuzzi A; Marzullo P J Endocrinol Invest; 2003; 26(8 Suppl):46-9. PubMed ID: 15233212 [No Abstract] [Full Text] [Related]
6. The role of somatostatin analogs in the management of prostate cancer. Sinisi AA; Rossi V; Prezioso D; Notaro A; Bellastella G; Panza N; Bellastella A; Pasquali D J Endocrinol Invest; 2003; 26(8 Suppl):120-4. PubMed ID: 15233227 [No Abstract] [Full Text] [Related]
7. The role of somatostatin analogs in the control of tumor growth. Lamberts SW; Reubi JC; Krenning EP Semin Oncol; 1994 Oct; 21(5 Suppl 13):61-4. PubMed ID: 7992085 [No Abstract] [Full Text] [Related]
8. The role of somatostatin analogs in the management of immunoproliferative disease. Ferone D; Arvigo M; Semino C; Pivonello R; van Hagen PM; Barreca A; Minuto F J Endocrinol Invest; 2003; 26(8 Suppl):103-8. PubMed ID: 15233223 [No Abstract] [Full Text] [Related]
9. Conclusions: the future role of somatostatin analogs. Lamberts SW J Endocrinol Invest; 2003; 26(8 Suppl):134-5. PubMed ID: 15233230 [No Abstract] [Full Text] [Related]
10. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment. Janson ET; Oberg K Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762 [No Abstract] [Full Text] [Related]
11. Rationale of pre-surgical medical treatment with somatostatin analogs in acromegaly. Cappabianca P; Cavallo LM; Esposito F; Romano I; Colao A; de Divitiis E J Endocrinol Invest; 2003; 26(8 Suppl):55-8. PubMed ID: 15233214 [No Abstract] [Full Text] [Related]
12. Chemotherapy targeted to cancers through tumoral hormone receptors. Schally AV; Nagy A Trends Endocrinol Metab; 2004 Sep; 15(7):300-10. PubMed ID: 15350601 [TBL] [Abstract][Full Text] [Related]
13. Biology of somatostatin in breast cancer. Watt HL; Kharmate G; Kumar U Mol Cell Endocrinol; 2008 May; 286(1-2):251-61. PubMed ID: 18308465 [TBL] [Abstract][Full Text] [Related]
16. Role of somatostatin analogs in the clinical management of non-neuroendocrine solid tumors. Kvols LK; Woltering EA Anticancer Drugs; 2006 Jul; 17(6):601-8. PubMed ID: 16917205 [TBL] [Abstract][Full Text] [Related]
17. Responsiveness to somatostatin analog treatment and potentials of novel somatostatin analog. Hofland LJ J Endocrinol Invest; 2003; 26(8 Suppl):8-13. PubMed ID: 15233204 [No Abstract] [Full Text] [Related]
18. Management of breast cancer: is there a role for somatostatin and its analogs? Boccardo F; Amoroso D Chemotherapy; 2001; 47 Suppl 2():62-77. PubMed ID: 11275703 [TBL] [Abstract][Full Text] [Related]
19. The role of somatostatin analogs in the management of hepatocellular carcinoma. D'Agostino L; Manguso F; Pivonello R; Colao A J Endocrinol Invest; 2003; 26(8 Suppl):131-3. PubMed ID: 15233229 [No Abstract] [Full Text] [Related]
20. Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors. Pivonello R; Ferone D; Filippella M; Faggiano A; De Martino MC; Auriemma RS; Rota F; Lombardi G; Colao A J Endocrinol Invest; 2003; 26(8 Suppl):82-8. PubMed ID: 15233220 [No Abstract] [Full Text] [Related] [Next] [New Search]